Showing results (771-780 of 1,128) with videos related to

Sort By:
Pageof 113
American Journal of Clinical Oncology|August 1, 1995
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group studyJ L Clark, O Küçük, D S Neuberg, et al.
Investigational New Drugs|January 1, 1994
Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trialM R Mullane, R L Schilsky, R B Carroll, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 4, 2007
Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosisDinesh Khanna, Daniel E Furst, Weng Kee Wong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2011
Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantationAlexander B Benson, James R Burton, Gregory L Austin, et al.
Investigational New Drugs|September 22, 2010
Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabineLaura W Goff, Al B Benson, Patricia M LoRusso, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolizationRyan Hickey, Mary F Mulcahy, Robert J Lewandowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704Adam C Berger, Miguel Garcia, John P Hoffman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1996
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, H Wagner, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingJulia R Trosman, Christine B Weldon, William J Gradishar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trialAdam C Berger, Kathryn Winter, John P Hoffman, et al.
Pageof 113